ImmuCell Corporation (ICCC) Stock Analysis

ImmuCell Corporation (ICCC) is a publicly traded company in the HEALTHCARE sector. It trades at $9.79, carries a market capitalization of $87.48M. This page summarizes the public market data, fundamentals, and frequently asked questions for ICCC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.79
• Market Cap: $87.48M
• EPS: $-0.07
• 52-Week High: $10.75
• 52-Week Low: $4.52

Market Sentiment

ImmuCell Corporation currently has a Neutral sentiment score of 0.00.

About ImmuCell Corporation

ImmuCell Corporation (ICCC) is a prominent player in the animal health industry, dedicated to enhancing the well-being and productivity of dairy and beef cattle through cutting-edge biological products. Based in Portland, Maine, the company focuses on the development and commercialization of proprietary solutions that significantly improve livestock health and performance. ImmuCell prides itself on its commitment to sustainability and innovative practices, positioning itself to leverage growt...

GNG Research Analysis

GNG Research scores ImmuCell Corporation (ICCC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ICCC.

Frequently Asked Questions

Does ICCC pay dividends?

ImmuCell Corporation (ICCC) does not currently pay a regular dividend.

What is ICCC's market cap?

ImmuCell Corporation (ICCC) has a market capitalization of $87.48M with a current stock price of $9.79.